"Lorazepam" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
| Descriptor ID |
D008140
|
| MeSH Number(s) |
D03.633.100.079.080.070.450
|
| Concept/Terms |
Ativan- Ativan
- Orfidal Wyeth
- Wyeth, Orfidal
- Témesta
|
Below are MeSH descriptors whose meaning is more general than "Lorazepam".
Below are MeSH descriptors whose meaning is more specific than "Lorazepam".
This graph shows the total number of publications written about "Lorazepam" by people in this website by year, and whether "Lorazepam" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lorazepam" by people in Profiles.
-
Lawal OD, Meador KJ, Hume AL, Wen X. Utilization of Antiseizure Medications in Women of Childbearing Age With Epilepsy and Nonepilepsy Indications: A Retrospective Cohort Study. Neurology. 2023 09 05; 101(10):e1083-e1096.
-
Kamdar HA, Hamed M, Smetana KS, Shanmugam K, Peters E, Yasin R, Thakur G, Gopal M, Sawalha K, Greene-Chandos D, Hussein O. Lorazepam timing for acute convulsive seizure control (LoTASC). Seizure. 2020 Dec; 83:41-47.
-
Rossi KC, Brandstadter R, Fields MC, Leong J, Shin S. Clinical Reasoning: A 54-year-old woman with confusion and visual disturbances. Neurology. 2018 08 21; 91(8):363-367.
-
Sen S, Grgurich P, Tulolo A, Smith-Freedman A, Lei Y, Gray A, Dargin J. A Symptom-Triggered Benzodiazepine Protocol Utilizing SAS and CIWA-Ar Scoring for the Treatment of Alcohol Withdrawal Syndrome in the Critically Ill. Ann Pharmacother. 2017 Feb; 51(2):101-110.
-
Burns JM, Marino A, Manno M, Rhyee S, Boyer EW. Status epilepticus in a child secondary to ingestion of skin-lightening cream. Pediatr Emerg Care. 2013 May; 29(5):662-4.
-
Kent K, Ganetsky M, Cohen J, Bird S. Non-fatal ventricular dysrhythmias associated with severe salicylate toxicity. Clin Toxicol (Phila). 2008 Apr; 46(4):297-9.
-
Fong JJ, Kanji S, Dasta JF, Garpestad E, Devlin JW. Propofol associated with a shorter duration of mechanical ventilation than scheduled intermittent lorazepam: a database analysis using Project IMPACT. Ann Pharmacother. 2007 Dec; 41(12):1986-91.
-
Devlin JW, Fong JJ, Schumaker GL. Identifying factors that could account for differences in duration of mechanical ventilation between intermittent lorazepam- and propofol-treated patients. Crit Care Med. 2006 Dec; 34(12):3063-4; author reply 3064.
-
Sperling R, Greve D, Dale A, Killiany R, Holmes J, Rosas HD, Cocchiarella A, Firth P, Rosen B, Lake S, Lange N, Routledge C, Albert M. Functional MRI detection of pharmacologically induced memory impairment. Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):455-60.
-
Rathlev NK, Ulrich A, Fish SS, D'Onofrio G. Clinical characteristics as predictors of recurrent alcohol-related seizures. Acad Emerg Med. 2000 Aug; 7(8):886-91.